The Hong Kong stock biotech and pharmaceutical sector continues to rise, with WuXi AppTec up over 10%

The Hong Kong stock market’s biopharmaceutical sector continues to rise, with WuXi AppTec up over 10%, WuXi Biologics up over 9%, and CanSino Biologics-B, Akeso, and Innovent Biologics all climbing.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments